Latest News in the pharma Industry
Research & Development
FDA approves Allergan's sNDA for Avycaz to include new Phase III data in patients with cUTI
30 Jan 2017
New clinical data for Avycaz demonstrates efficacy in cUTI patients including those with infections due to resistant Gram-negative pathogens.
Read more
First adalimumab biosimilar candidate recommended for EMA approval
29 Jan 2017
Amgen receives positive CHMP opinion for biosimilar adalimumab.
Read more
J&J to acquire Acelion for $30 B with spin-out of new R&D company
29 Jan 2017
Actelion R&D unit to spin out into standalone company based and listed in Switzerland.
Read more
X4 Pharma initiates clinical study of X4P-001 in combination with Opdivo
28 Jan 2017
Combination studied as treatment for patients with advanced clear cell renal cell carcinoma.
Read more
Non-opiate painkiller, AnestaGel, found superior in preclinical tests
26 Jan 2017
AnestaGel uses a novel approach to delivering sustained-released analgesics into the target tissue via the Matrix, which is a tunable, biocompatible, and pH neutral platform.
Read more
Axim Biotech enters IBS clinical trial for CanChew CBD chewing gum
26 Jan 2017
Clinical trial is the first of its kind to treat IBS symptoms by cannabinoid-containing chewing gum.
Read more
Clinerion introduces new services for market access
25 Jan 2017
Disease prevalence can be monitored with a precision never before possible.
Read more
Zymeworks opens state-of-the-art lab facility
25 Jan 2017
Provides the company with increased control over discovery research, antibody generation, medicinal chemistry and bioconjugation for generating antibody drug conjugates.
Read more
FDA approves IND for Vectura's VR647
24 Jan 2017
VR647 is a drug/device combination, using the AKITA JET smart nebuliser, for the delivery of nebulised budesonide.
Read more
Enteris and Sanofi to develop oral therapeutic for type 2 diabetes
25 Jan 2017
Feasibility study to examine three different oral formulations engineered with Enteris’ Peptelligence platform.
Read more
Enamine expands collaboration with Europe’s largest biopharmaceutical company
23 Jan 2017
Extends multi-year agreement in drug discovery with focus on cardiovascular and central nervous system disorders, immunology, infectious diseases and oncology.
Read more
Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic
23 Jan 2017
The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years.
Read more